The kinase inhibitor p21−Cip1 and the oncogene c-Myc are the two target genes by which TGF-β maintains tissue homeostasis, inhibiting the progression of tumor cells to the cell cycle phase G1 [25]. The gene discussed is TGFB1; the disease is neoplasm.